1. Home
  2. ASYS vs AVTX Comparison

ASYS vs AVTX Comparison

Compare ASYS & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amtech Systems Inc.

ASYS

Amtech Systems Inc.

HOLD

Current Price

$23.99

Market Cap

330.8M

Sector

Technology

ML Signal

HOLD

Logo Avalo Therapeutics Inc.

AVTX

Avalo Therapeutics Inc.

HOLD

Current Price

$14.76

Market Cap

328.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASYS
AVTX
Founded
1981
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
330.8M
328.4M
IPO Year
2006
2015

Fundamental Metrics

Financial Performance
Metric
ASYS
AVTX
Price
$23.99
$14.76
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$40.57
AVG Volume (30 Days)
357.2K
1.4M
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
72.07
EPS
0.09
N/A
Revenue
$79,364,000.00
$27,813,137.00
Revenue This Year
$2.82
N/A
Revenue Next Year
$18.75
N/A
P/E Ratio
$248.10
N/A
Revenue Growth
N/A
2312.27
52 Week Low
$3.93
$4.46
52 Week High
$24.50
$24.27

Technical Indicators

Market Signals
Indicator
ASYS
AVTX
Relative Strength Index (RSI) 63.10 47.23
Support Level $6.96 $13.22
Resistance Level N/A $15.63
Average True Range (ATR) 2.22 0.93
MACD -0.01 -0.16
Stochastic Oscillator 82.02 53.09

Price Performance

Historical Comparison
ASYS
AVTX

About ASYS Amtech Systems Inc.

Amtech Systems Inc provides equipment, consumables and services for semiconductor device packaging, wafer production and device fabrication. Its products are used to fabricate and package GPUs for AI applications, SiC and Si power devices, and other optical, analog and digital devices, and are sold to semiconductor packaging, electronic assembly and device fabrication companies. It operates through two segments: Thermal Processing Solutions, which includes conveyorized reflow equipment, high-temperature conveyorized furnaces and diffusion furnaces with maximum revenue; and Semiconductor Fabrication Solutions, which includes consumables, equipment and services for wafer polishing, dicing and cleaning. The majority of revenue is derived from the United States.

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.

Share on Social Networks: